CXCL12 and hereditary hemorrhagic telangiectasia: Using an in vitro migration assay, we found that CACs from either HHT patients had a reduced migration towards VEGF and SDF1 as compared to CACs from healthy volunteers, suggesting CAC mobilization in HHT patients is compromised.